Alumni raised $1.45B in 2022 - Download Free Report Now


Fast-track development of novel drugs for an unmet medical need - Alzheimer\'s disease - with rapid payback on investment.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of ADispell plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About ADispell

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups


Companies We Work With